Clinical and Legal Dilemmas of Providing Reproductive Health Care After the Dobbs Decision

Michele Bratcher Goodwin, JD (Center for Biotechnology and Global Health Policy, University of California, Irvine), Molly Meegan, JD (American College of Obstetricians and Gynecologists), and Lisa Harris, MD, PhD (University of Michigan) discuss how new abortion bans in the US are creating serious legal and ethical dilemmas for clinicians. Hosted by JAMA Legal and Global Health Correspondent Lawrence O. Gostin, JD (Georgetown University).

Related Content:

Legal Risks and Ethical Dilemmas for Clinicians in the Aftermath of Dobbs

The Future of Ob-Gyn Training in the US Post-Dobbs

Medical Indications for Abortion

Podcast was originally published on November 1, 2022.

Conflict of Interest Disclosures:

Lawrence O. Gostin, JD, is the Legal and Global Health Correspondent for JAMA and Faculty Director of the O’Neill Institute for National and Global Health Law at Georgetown University. No other disclosures were reported.

Michele Bratcher Goodwin, JD, LLM, SJD is Director of the Center for Biotechnology and Global Health Policy at University of California, Irvine. No other disclosures were reported. Lisa Harris, MD, PhD, is the F. Wallace and Janet Jeffries Collegiate Professor of Reproductive Health, and Professor and Associate Chair in the Department of Obstetrics and Gynecology at University of Michigan. She is also a Professor in the Department of Women’s Studies. No other disclosures reported. Molly Meegan is the Chief Legal Officer and General Counsel for the American College of Obstetricians and Gynecologists (ACOG). No other disclosures reported.

---------------------------------------------------------------------------------
Follow JAMA Clinical Reviews on:

---------------------------------------------------------------------------------
For more from JAMA

Follow the JAMA Network